Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 06 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-0.45 Insider Own14.54% Shs Outstand35.12M Perf Week7.01%
Market Cap337.85M Forward P/E61.40 EPS next Y0.16 Insider Trans1.56% Shs Float30.01M Perf Month-28.16%
Income-14.21M PEG- EPS next Q-0.04 Inst Own70.96% Short Float / Ratio20.35% / 8.88 Perf Quarter-35.44%
Sales114.17M P/S2.96 EPS this Y-1.31% Inst Trans-4.61% Short Interest6.11M Perf Half Y-54.15%
Book/sh2.16 P/B4.46 EPS next Y130.32% ROA-7.38% Target Price28.13 Perf Year-22.36%
Cash/sh2.10 P/C4.57 EPS next 5Y15.00% ROE-36.92% 52W Range7.60 - 28.25 Perf YTD-34.82%
Dividend- P/FCF- EPS past 5Y3.03% ROI-5.37% 52W High-65.95% Beta0.41
Dividend %- Quick Ratio5.33 Sales past 5Y28.85% Gross Margin69.78% 52W Low26.58% ATR0.66
Employees217 Current Ratio5.80 Sales Q/Q50.13% Oper. Margin3.09% RSI (14)39.26 Volatility4.51% 6.63%
OptionableYes Debt/Eq2.50 EPS Q/Q45.77% Profit Margin-12.44% Rel Volume0.52 Prev Close9.40
ShortableYes LT Debt/Eq2.49 EarningsNov 13 AMC Payout- Avg Volume687.85K Price9.62
Recom1.00 SMA20-4.04% SMA50-23.62% SMA200-46.14% Volume354,607 Change2.34%
Date Action Analyst Rating Change Price Target Change
Sep-08-22Resumed B. Riley Securities Buy $17
Oct-14-21Resumed B. Riley Securities Buy $16
Sep-24-21Initiated Aegis Capital Buy $15
Jul-02-21Initiated Ladenburg Thalmann Buy $14.25
Nov-29-23 07:00AM
Nov-20-23 07:00AM
Nov-14-23 12:56PM
Nov-13-23 05:07PM
08:00AM Loading…
Oct-30-23 08:00AM
Oct-24-23 07:00AM
Sep-29-23 08:00AM
Sep-26-23 08:00AM
Sep-21-23 01:03PM
Aug-11-23 01:05PM
Aug-10-23 09:54AM
Aug-09-23 04:14PM
Jul-31-23 07:00AM
02:56PM Loading…
Jul-28-23 02:56PM
Jul-26-23 03:42PM
Jul-20-23 10:29AM
Jul-19-23 12:17PM
Jul-18-23 05:00PM
Jul-05-23 06:15PM
Jun-29-23 06:15PM
Jun-23-23 06:15PM
Jun-16-23 06:00PM
May-17-23 08:00AM
11:57AM Loading…
May-16-23 11:57AM
May-15-23 11:21AM
May-12-23 01:48PM
May-11-23 05:15PM
May-08-23 12:07PM
May-04-23 08:00AM
May-03-23 06:44AM
May-02-23 04:42PM
May-01-23 08:50AM
Apr-28-23 06:00PM
Apr-27-23 08:05AM
Apr-24-23 08:43AM
Apr-20-23 08:31AM
Apr-19-23 06:15PM
Apr-18-23 06:24AM
Apr-14-23 08:50AM
Apr-13-23 06:15PM
Apr-12-23 09:40AM
Apr-09-23 04:04PM
Apr-05-23 09:34AM
Apr-04-23 05:37AM
Apr-03-23 06:53AM
Mar-29-23 08:50AM
Mar-28-23 02:59PM
Mar-27-23 08:51AM
Mar-24-23 05:42AM
Mar-23-23 04:06PM
Mar-13-23 07:00AM
Mar-06-23 08:00AM
Mar-02-23 08:00AM
Feb-16-23 06:42AM
Feb-15-23 07:00AM
Feb-03-23 08:50AM
Feb-02-23 06:30AM
Jan-23-23 07:00AM
Jan-21-23 07:33AM
Jan-18-23 08:50AM
Jan-05-23 07:00AM
Dec-25-22 07:24AM
Dec-21-22 09:21AM
Dec-16-22 07:00AM
Dec-14-22 03:24PM
Nov-30-22 08:00AM
Nov-16-22 05:06AM
Nov-14-22 04:05PM
Nov-10-22 08:00AM
Oct-28-22 08:00AM
Oct-27-22 08:00AM
Oct-13-22 09:35AM
Oct-06-22 03:23PM
Oct-05-22 05:35PM
Sep-29-22 07:00AM
Sep-28-22 07:09AM
Sep-27-22 01:50PM
Sep-21-22 06:01PM
Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BAUM MARK LChief Executive OfficerNov 16Buy8.117,50060,8252,022,961Nov 16 04:45 PM
Opaleye Management Inc.10% OwnerNov 15Buy8.0325,000200,7353,645,000Nov 16 04:05 PM
Opaleye Management Inc.10% OwnerSep 20Buy14.495,98386,7103,620,000Sep 20 06:39 PM
Opaleye Management Inc.10% OwnerSep 19Buy14.6514,017205,3663,614,017Sep 20 06:39 PM
Makary Martin A.DirectorAug 14Buy16.9220,000338,40045,000Aug 15 07:30 AM
BAUM MARK LChief Executive OfficerAug 14Buy17.055,80098,8902,015,461Aug 15 07:30 AM
BAUM MARK LChief Executive OfficerApr 03Option Exercise8.99180,0001,618,2001,664,962Apr 04 07:54 PM
BOLL ANDREW R.Chief Financial OfficerMar 31Option Exercise6.0090,000540,000358,461Apr 04 07:50 PM
BAUM MARK LChief Executive OfficerDec 22Buy13.3925,000334,7501,432,141Dec 23 07:03 AM
BOLL ANDREW R.Chief Financial OfficerDec 22Buy13.542,50033,850255,063Dec 23 07:02 AM
Van Horn R. LawrenceDirectorDec 22Buy13.421,86024,9611,860Dec 23 07:00 AM
Makary Martin A.DirectorDec 21Buy13.3725,000334,25025,000Dec 23 07:01 AM
Opaleye Management Inc.10% OwnerDec 14Buy10.52431,1834,536,0453,600,000Dec 14 04:05 PM